1. University of Kragujevac Digital Archive
  2. University of Kragujevac
  3. Faculty of Medical Sciences, Kragujevac
Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/10523
Full metadata record
DC FieldValueLanguage
dc.rights.licenserestrictedAccess-
dc.contributor.authorPetrovska S.-
dc.contributor.authorDejanova B.-
dc.contributor.authorJurisic, Vladimir-
dc.date.accessioned2021-04-20T15:58:34Z-
dc.date.available2021-04-20T15:58:34Z-
dc.date.issued2012-
dc.identifier.issn1138-7548-
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/10523-
dc.description.abstractWithin the last few years, there has been a growing interest in the neuroprotective effects of estrogen and the possible beneficial effects of estrogen in neurodegenerative diseases such as stroke, Alzheimer's disease, and Parkinson's disease. The concept of neuroprotective effects of estrogen in women remains controversial because these effects may vary with the timing of treatment. Research increasingly suggests that changes in estrogen levels during aging may increase risk for Alzheimer's disease, the most common type of dementia. This update reviews the newest information about estrogen and cognitive aging, including information regarding the role of bioavailable estrogen in older women and men. © University of Navarra 2012.-
dc.rightsinfo:eu-repo/semantics/restrictedAccess-
dc.sourceJournal of Physiology and Biochemistry-
dc.titleEstrogens: Mechanisms of neuroprotective effects-
dc.typereview-
dc.identifier.doi10.1007/s13105-012-0159-x-
dc.identifier.scopus2-s2.0-84871259242-
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

485

Downloads(s)

7

Files in This Item:
File Description SizeFormat 
PaperMissing.pdf
  Restricted Access		29.86 kBAdobe PDFThumbnail
View/Open
Show simple item record


Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.